Skip to main content
UniHealth

Doctor search

Marie E Rinaldi, NP

Nurse Practitioner · Burlingame

NPI 1952705113

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
3
1 carrier
Offices
2
Since medical school
12 years
Graduated 2014

Offices

2 locations · UCSF Medical Group Business Services · 1,533 clinicians in this group

Looking this up.

Hospitals listed: Mills-Peninsula Medical Center · UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

3 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Marie E Rinaldi’s office at (650) 341-9131 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Peninsula Medical Center
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.139BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.242BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.21 (0.27 to 2.15) · 1,258 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.81 (0.51 to 1.1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths155.44 (112.67 to 198.21) · 90 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 32 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 82 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10 · 188 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9 · 473 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.8 · 342 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.4 · 485 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 3,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.2 (0 to 0.4) · 6,904 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 7,052 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.41 (1.43 to 5.39) · 1,695 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.72 (0.17 to 3.28) · 665 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.66 to 3.56) · 1,545 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.1 (1.3 to 12.9) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.96 (2.63 to 9.29) · 653 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.15 to 3.08) · 418 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.14 (0 to 0.78) · 5,539 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.7 · 192 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.215No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.263No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.74No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.3 · 300 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19 · 702 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits1.2 · 207 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-13.6 · 531 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits24.3 · 343 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.1 · 449 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.5 (2.8 to 7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits9.6 (6.7 to 13.7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 189 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11 · 45 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.6 · 117 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13 (9.7 to 17.2) · 584 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 764 casesNo differentJan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Patient survey stars by topic at Peninsula Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Peninsula Medical Center
Room was "always" clean76%
Nurses "always" communicated well81%
Doctors "always" communicated well80%
Staff "always" explained58%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$37,715

Medicare paid this office $37,715 for 96 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)85$30,150$140
Return visit (30+ min)30$4,361$104
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's60$1,446$12
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or22$520$22

Procedures year by year

Procedures billed to Original Medicare by year
Procedure20202021202220232024
Collection of blood sample from implanted device16592–––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

96 Original Medicare patients in 2024. Average age 78 · Women 40% · Health risk score 2.75. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 65% · Cancer 65% · Chronic kidney disease 30% · Diabetes 28% · Coronary heart disease 28% · Heart failure 23% · COPD 21% · Atrial fibrillation 20% · Depression 18%.

The office billed $212,937, Medicare allowed $48,778 and paid $37,715; for 408 services of 9 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202496408782.75$212,937$37,715
2023115380772.37$225,599$39,546
2022108276772.13$153,131$27,125
202118347,506772.56$4,994,948$587,939
202015130,390762.35$2,389,976$274,943

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Original Medicare services billed in 2023
Long return visit (40+ min)74$17,784$141
Return visit (30+ min)76$16,581$98
Short return visit (20+ min)29$3,515$64
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or18$499$25

2022: 3 services

Original Medicare services billed in 2022
Return visit (30+ min)86$19,159$101
Long return visit (40+ min)21$3,700$137
Short return visit (20+ min)37$3,412$68

2021: 15 services

Original Medicare services billed in 2021
Injection, denosumab, 1 mg37$188,714None
Leuprolide acetate (for depot suspension), 7.5 mg28$26,379None
Return visit (30+ min)45$6,865$101
Short return visit (20+ min)48$6,780$73
Administration of chemotherapy into vein, 1 hour or less28$6,066$132
Injection of drug or substance under skin or into muscle60$2,589$11
Collection of blood sample from implanted device22$2,232$24
Long return visit (40+ min)12$1,909$127
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle31$1,658$24
Administration of additional new drug or substance into vein, 1 hour or less14$1,271$64
Injection of additional new drug or substance into vein18$829$15
Injection, carboplatin, 50 mg11$273None
Infusion, normal saline solution , 1000 cc38$157None
5% dextrose/water (500 ml = 1 unit)15$39None
Injection, heparin sodium, (heparin lock flush), per 10 units12$17None

2020: 9 services

Original Medicare services billed in 2020
Injection, denosumab, 1 mg24$137,312None
Leuprolide acetate (for depot suspension), 7.5 mg30$22,811None
Collection of blood sample from implanted device32$4,420$27
Return visit (30+ min)32$3,751$89
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle32$1,722$27
Injection of drug or substance under skin or into muscle32$1,493$11
Telephone medical discussion with physician, 21-30 minutes14$1,291$81
Injection, heparin sodium, (heparin lock flush), per 10 units33$84None
Infusion, normal saline solution , 1000 cc22$65None

Drugs they prescribed that Part D paid

$1,623,951

Pharmacies billed $1,623,951 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 4% of their Part D prescriptions (24 of 584) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

433 generic and 151 brand-name prescriptions · $1,623,951 in drug cost · 17 antibiotic prescriptions to 13 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Imbruvica33$485,181$14,702
Lenalidomide14$152,774$10,912
Eliquis28$24,240$866
Abiraterone Acetate19$4,973$262
Anastrozole48$1,374$29
See all 14 drugs
Every Part D drug this clinician prescribed
Imbruvica33$485,181$14,702
Lenalidomide14$152,774$10,912
Eliquis28$24,240$866
Abiraterone Acetate19$4,973$262
Anastrozole48$1,374$29
Hydroxyurea16$697$44
Valacyclovir15$589$39
Prednisone71$291$4
Letrozole12$242$20
Hydrocodone-Acetaminophen16$216$14
Loperamide15$210$14
Levothyroxine11$110$10
Lorazepam18$96$5
Omeprazole12$43$4

Year by year

Part D prescribing by year
20245841584% (24)26%$1,623,951
20239572784% (37)None$3,472,750
20228622305% (45)None$4,432,035
20219502374% (40)None$4,466,813
20203201154% (14)None$1,414,452
20194420NoneNone$78,155
20186526NoneNone$10,044
20177934None19%$102,488
20164120NoneNone$9,184
201515NoneNoneNone$4,768

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 31 drugs

Part D drugs prescribed in 2023
Pomalyst22$497,897$22,632
Imbruvica29$414,230$14,284
Xtandi39$409,615$10,503
Inlyta13$297,851$22,912
Revlimid16$279,783$17,486
Jakafi12$271,216$22,601
Tagrisso11$206,384$18,762
Erleada11$169,605$15,419
Abiraterone Acetate33$61,116$1,852
Orgovyx15$39,434$2,629
Eliquis32$32,366$1,011
Imatinib Mesylate11$14,731$1,339
Anastrozole107$3,531$33
Hydroxyurea26$1,707$66
Letrozole27$1,423$53
Acyclovir30$1,036$35
Valacyclovir16$896$56
Ondansetron43$489$11
Prednisone58$439$8
Hydrocodone-Acetaminophen24$416$17
Diphenoxylate-Atropine11$357$32
Potassium Chloride15$325$22
Prochlorperazine Maleate19$306$16
Pantoprazole18$291$16
Lidocaine-Prilocaine17$261$15
Dexamethasone12$220$18
Sulfamethoxazole-Trimethoprim29$204$7
Levothyroxine13$174$13
Nystatin12$135$11
Gabapentin15$133$9
Lorazepam16$69$4

2022: 19 drugs

Part D drugs prescribed in 2022
Revlimid71$1,211,097$17,058
Imbruvica78$1,162,050$14,898
Pomalyst26$556,365$21,399
Zejula11$184,760$16,796
Jakafi15$81,836$5,456
Abiraterone Acetate51$75,150$1,474
Eliquis34$27,262$802
Xarelto11$5,820$529
Anastrozole86$2,489$29
Hydroxyurea15$962$64
Letrozole18$750$42
Dexamethasone23$537$23
Ondansetron17$477$28
Prednisone63$365$6
Potassium Chloride14$360$26
Hydrocodone-Acetaminophen31$357$12
Gabapentin21$222$11
Prochlorperazine Maleate15$209$14
Lorazepam19$50$3

2021: 21 drugs

Part D drugs prescribed in 2021
Revlimid116$1,730,465$14,918
Imbruvica76$1,079,644$14,206
Tagrisso20$377,224$18,861
Pomalyst11$221,943$20,177
Abiraterone Acetate53$104,315$1,968
Eliquis35$24,215$692
Xarelto20$10,419$521
Anastrozole126$5,012$40
Hydroxyurea27$1,628$60
Letrozole20$1,022$51
Tamoxifen Citrate16$655$41
Prednisone67$596$9
Gabapentin32$381$12
Potassium Chloride15$294$20
Hydrocodone-Acetaminophen17$269$16
Allopurinol15$228$15
Hydrocortisone13$179$14
Ondansetron14$154$11
Famotidine14$154$11
Pantoprazole11$129$12
Lorazepam13$54$4

2020: 6 drugs

Part D drugs prescribed in 2020
Revlimid54$727,377$13,470
Imbruvica12$159,051$13,254
Abiraterone Acetate16$23,620$1,476
Anastrozole33$1,600$48
Prednisone24$214$9
Ondansetron11$160$15

2016: 1 drug

Part D drugs prescribed in 2016
Ondansetron15$372$25

Money from drug and device companies

$24 in 2025

Industry payments by year
202511None$24
202411None$27
202311None$31
202126None$196

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Salix Pharmaceuticals a division of Bausch Health USXifaxan$24
1 payment
  • Meals for Xifaxan · 2025-03-17 · $24
See the published payment
Every published payment
Salix Pharmaceuticals a division of Bausch Health USMeals · 2025-03-17Xifaxan$24
See earlier years (2024, 2023, 2021)

2024: $27

Payments by company in 2024
Janssen BiotechTecvayli$27
1 payment
  • Meals for Tecvayli · 2024-03-08 · $27

2023: $31

Payments by company in 2023
PfizerIbrance$31
1 payment
  • Education for Ibrance · 2023-05-22 · $31

2021: $196

Payments by company in 2021
PfizerInlyta$184
5 payments
  • Education for Inlyta · 2021-12-15 · $26
  • Education for Lorbrena · 2021-10-26 · $18
  • Education for Inlyta · 2021-10-22 · $8
  • Education for Inlyta · 2021-05-12 · $8
  • Education for Inlyta · 2021-05-12 · $124
Janssen BiotechErleada$12
1 payment
  • Meals for Erleada · 2021-05-01 · $12

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
75.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1952705113
Licence
CA 95001555
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 363LA2100X (363LA2100X)
Mailing address
300 Pasteur Drive, Mc 5221, Stanford, CA, 94305
NPI first listed
2014-10-17
NPI last updated
2014-12-23

This is when the NPI record was last certified, not a medical board exam.